Physical Address

304 North Cardinal St.
Dorchester Center, MA 02124

FDA approves Gamifant ® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still's disease




FDA approves Gamifant ® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still’s disease



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *